Los puntos clave no están disponibles para este artículo en este momento.
Administering additional cladribine courses is an effective option to maintain disease control and did not trigger any serious adverse events attributable to the therapy. Patients with elevated serum transaminase levels should be regularly monitored.
Kleinschnitz et al. (Tue,) studied this question.